Pharmaceutical
| Tue 06 Oct 2026
Alexandria, Oct. 5 -- C4 Therapeutics has received a patent for Selected Compounds for Targeted Degradation of BRD9. This invention was developed by Zhang Liwei, Veits Gesine Kerstin, Jiang Siyi, Neville Kathleen, Yu Robert T, Li Meiqi, Zeid Rhamy, Moustakim Moses, Schnaderbeck Matthew J, Yin Ning, He Minsheng, Yap Jeremy L, Liu..